JC Virus Infection of the Brain

References

1. 1.↵
   1. Padgett BL,
   2. Walker DL,
   3. Zu Rhein GM,
   4. et al

   . Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 29: 1257– 60
2. 2.↵
   1. Åström KE,
   2. Mancall EL,
   3. Richardson EP

   . Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81: 93– 111

   FREE Full Text
3. 3.↵
   1. Hartman EA,
   2. Huang D

   . Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment. Curr Hiv/AIDS Rep 2008; 5: 112– 19

   CrossRefPubMed
4. 4.↵
   1. Bofill-Mas S,
   2. Formiga-Cruz M,
   3. Clemente-Casares P,
   4. et al

   . Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75: 10290– 99

   Abstract/FREE Full Text
5. 5.↵
   1. Monaco MC,
   2. Jensen PN,
   3. Hou J,
   4. et al

   . Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72: 9918– 23

   Abstract/FREE Full Text
6. 6.↵
   1. Gheuens S,
   2. Pierone G,
   3. Peeters P,
   4. et al

   . Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 2010; 81: 247– 54

   Abstract/FREE Full Text
7. 7.↵
   1. Bienaime A,
   2. Colson P,
   3. Moreau J,
   4. et al

   . Progressive multifocal leukoencephalopathy in HIV-2-infected patient. AIDS 2006; 20: 1342– 43

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Stoner GL,
   2. Agostini HT,
   3. Ryschkewitsch CF,
   4. et al

   . Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient. J Med Microbiol 1998; 47: 733– 42

   Abstract/FREE Full Text
9. 9.↵
   1. d'Arminio Monforte A,
   2. Cinque P,
   3. Mocroft A,
   4. et al

   . Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55: 320– 28

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Lang W,
    2. Miklossy J,
    3. Deruaz JP,
    4. et al

    . Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 1989; 77: 379– 90

    CrossRefPubMed
11. 11.↵
    1. Cinque P,
    2. Vago L,
    3. Dahl H,
    4. et al

    . Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 1996; 10: 951– 58

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Falco V,
    2. Olmo M,
    3. del Saz SV,
    4. et al

    . Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study. J Acquir Immune Defic Syndr 2008; 49: 26– 31

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Mocroft A,
    2. Sterne JA,
    3. Egger M,
    4. et al

    . Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis 2009; 48: 1138– 51

    Abstract/FREE Full Text
14. 14.↵
    1. Lewden C,
    2. May T,
    3. Rosenthal E,
    4. et al

    . Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48: 590– 98

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Garcia-Suarez J,
    2. deMiguel D,
    3. Krsnik I,
    4. et al

    . Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol 2005; 80: 271– 81

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Shitrit D,
    2. Lev N,
    3. Bar-Gil-Shirit A,
    4. et al

    . Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 2005; 17: 658– 65

    CrossRefPubMed
17. 17.↵
    1. Kharfan-Dabaja MA,
    2. Ayala E,
    3. Greene J,
    4. et al

    . Two cases of progressive multifocal leukoencephalopathy after allogenic hematopoietic cell transplantation and review of the literature. Bone Marrow Transplant 2007; 39: 101– 07

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Calabrese LH,
    2. Molloy ES,
    3. Huang D,
    4. et al

    . Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathological patterns of disease. Arthritis Rheum 2007; 56: 2116– 28

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Hayashi Y,
    2. Kimura A,
    3. Kato S,
    4. et al

    . Progressive multifocal leukoencephalopathy and CD4+ T-lymphocytopenia in a patient with Sjögren syndrome. J Neurol Sci 2008; 268: 195– 98

    CrossRefPubMedWeb of Science
20. 20.↵
    1. De Raedt S,
    2. Lacor P,
    3. Michotte A,
    4. et al

    . Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. Clin Neurol Neurosurg 2008; 110: 186– 89

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Van Assche G,
    2. Van Ranst M,
    3. Sciot R,
    4. et al

    . Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005; 353: 362– 68

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Kleinschmidt-DeMasters BK,
    2. Tyler KL

    . Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369– 74

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Langer-Gould A,
    2. Atlas SW,
    3. Green AJ,
    4. et al

    . Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375– 81

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Molloy ES,
    2. Calabrese LH

    . Therapy: targeted but not trouble-free—efalizumab and PML. Nat Rev Rheumatol 2009; 5: 418– 19

    CrossRefPubMed
25. 25.↵
    1. Carson KR,
    2. Focosi D,
    3. Major EO,
    4. et al

    . Monoclonal antibody associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 2009; 10: 816– 24

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Tyler KL

    . Emerging viral infections of the central nervous system: part 2. Arch Neurol 2009; 66: 1065– 74

    CrossRefPubMed
27. 27.↵
    US Food and Drug Administration. Information for healthcare professionals: rituximab (marketed as Rituxan). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm126519.htm
28. 28.↵
    1. Haider S,
    2. Nafziger D,
    3. Gutierrez JA,
    4. et al

    . Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases. Clin Infect Dis 2000; 31: E20– 22

    CrossRefPubMed
29. 29.↵
    1. Chikezie PU,
    2. Grennberg AL

    . Idiopathic CD41 T lymphocytopenia presenting as progressive multifocal leukoencephalopathy: case report. Clin Infect Dis 1997; 24: 526– 27

    FREE Full Text
30. 30.↵
    1. Iwase T,
    2. Kosei O,
    3. Katada E,
    4. et al

    . An unusual course of progressive multifocal leukoencephalopathy in a patient with idiopathic CD41 T lymphocytopenia. J Neurol Neurosurg Psychiatry 1998; 64: 788– 91

    Abstract/FREE Full Text
31. 31.↵
    1. Scotton PG,
    2. Vaglia A,
    3. Carniato A,
    4. et al

    . Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis 1998; 26: 215– 16

    FREE Full Text
32. 32.↵
    1. Narula S,
    2. LaRosa DF,
    3. Kamoun M,
    4. et al

    . Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 2007; 98: 483– 89

    PubMedWeb of Science
33. 33.↵
    1. Goldmann C,
    2. Petry H,
    3. Frye S,
    4. et al

    . Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol 1999; 73: 4465– 69

    Abstract/FREE Full Text
34. 34.↵
    1. Goldmann C,
    2. Stolte N,
    3. Nisslein T,
    4. et al

    . Packaging of small molecules into VP1-virus-like particles of the human polyomavirus JC virus. J Virol Methods 2000; 90: 85– 90

    CrossRefPubMed
35. 35.↵
    1. Weber T

    . Progressive multifocal leukoencephalopathy. Neurol Clin 2008; 26: 833– 54

    CrossRefPubMed
36. 36.↵
    1. Lednicky JA,
    2. Vilchez RA,
    3. Keitel WA,
    4. et al

    . Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17: 801– 07

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Tan CS,
    2. Dezube BJ,
    3. Bhargava P,
    4. et al

    . Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 2009; 199: 881– 88

    Abstract/FREE Full Text
38. 38.↵
    1. Cinque P,
    2. Koralnik IJ,
    3. Gerevini S,
    4. et al

    . Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis 2009; 9: 625– 36

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Jensen PN,
    2. Major EO

    . A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol 2001; 7: 280– 87

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Lima MA,
    2. Marzocchetti A,
    3. Autissier P,
    4. et al

    . Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007; 81: 3361– 68

    Abstract/FREE Full Text
41. 41.↵
    1. Berger JR

    . Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 2003; 9: 38– 41

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Cinque P,
    2. Bossolasco S,
    3. Brambilla AM,
    4. et al

    . The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J Neurovirol 2003; 9: 73– 80

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Khanna N,
    2. Elzi L,
    3. Mueller NJ,
    4. et al

    . Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009; 48: 1459– 66

    Abstract/FREE Full Text
44. 44.↵
    1. Gasnault J,
    2. Kahraman M,
    3. de Goer de Herve MG,
    4. et al

    . Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 2003; 17: 1443– 49

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Du Pasquier RA,
    2. Kuroda MJ,
    3. Zheng Y,
    4. et al

    . A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004; 127: 1970– 78

    Abstract/FREE Full Text
46. 46.↵
    1. Giudici B,
    2. Vaz B,
    3. Bossolasco S,
    4. et al

    . Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 2000; 30: 95– 99

    Abstract/FREE Full Text
47. 47.↵
    1. Berger JR,
    2. Pall L,
    3. Lanska D,
    4. et al

    . Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59– 68

    PubMedWeb of Science
48. 48.↵
    1. Lima MA,
    2. Drislane FW,
    3. Koralnik IJ

    . Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006; 66: 262– 64

    Abstract/FREE Full Text
49. 49.↵
    1. Whiteman ML,
    2. Post MJ,
    3. Berger JR,
    4. et al

    . Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993; 187: 233– 40

    PubMedWeb of Science
50. 50.↵
    1. Richardson EP Jr.

    . Progressive multifocal leukoencephalopathy. N Engl J Med 1961; 265: 815– 23

    PubMedWeb of Science
51. 51.↵
    1. Ng S,
    2. Tse VC,
    3. Rubinstein J,
    4. et al

    . Progressive multifocal leukoencephalopathy: unusual MR findings. J Comput Assist Tomogr 1995; 19: 302– 05

    PubMedWeb of Science
52. 52.↵
    1. Huang D,
    2. Cossoy M,
    3. Li M,
    4. et al

    . Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol 2007; 62: 34– 39

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Miralles P,
    2. Berenguer J,
    3. Lacruz C,
    4. et al

    . Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 2001; 15: 1900– 02

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Vendrely A,
    2. Bienvenu B,
    3. Gasnault J,
    4. et al

    . Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005; 109: 449– 55

    CrossRefPubMed
55. 55.↵
    1. Koralnik IJ,
    2. Wüthrich C,
    3. Dang X,
    4. et al

    . JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005; 57: 576– 80

    CrossRefPubMedWeb of Science
56. 56.↵
    1. Dang X,
    2. Koralnik IJ

    . A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol 2006; 87: 2533– 37

    Abstract/FREE Full Text
57. 57.↵
    1. Blake K,
    2. Pillay D,
    3. Knowles W,
    4. et al

    . JC virus associated meningoencephalitis in an immunocompetent girl. Arch Dis Child 1992; 67: 956– 57

    Abstract/FREE Full Text
58. 58.↵
    1. Behzad-Behbahani A,
    2. Klapper PE,
    3. Vallely PJ,
    4. et al

    . BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis. Infection 2003; 31: 374– 78

    PubMedWeb of Science
59. 59.↵
    1. Viallard JF,
    2. Ellie E,
    3. Lazaro E,
    4. et al

    . JC virus meningitis in a patient with systemic lupus erythematosus. Lupus 2005; 14: 964– 66

    Abstract/FREE Full Text
60. 60.↵
    1. Wüthrich C,
    2. Dang X,
    3. Westmoreland S,
    4. et al

    . Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 2009; 65: 742– 48

    CrossRefPubMedWeb of Science
61. 61.↵
    1. DeSimone JA,
    2. Pomerantz RJ,
    3. Babinchak TJ

    . Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133: 447– 54

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Shelburne SA,
    2. Montes M,
    3. Hamill RJ

    . Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006; 57: 167– 70

    Abstract/FREE Full Text
63. 63.↵
    1. Shelburne SA,
    2. Visnegarwala F,
    3. Darcourt J,
    4. et al

    . Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19: 399– 406

    CrossRefPubMedWeb of Science
64. 64.↵
    1. Shelburne SA,
    2. Darcourt J,
    3. White AC,
    4. et al

    . The role of immune reconstitution inflammatory syndrome in AIDS related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 1049– 52

    Abstract/FREE Full Text
65. 65.↵
    1. Price P,
    2. Morahan G,
    3. Huang D,
    4. et al

    . Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16: 2043– 47

    CrossRefPubMedWeb of Science
66. 66.↵
    1. Stoll M,
    2. Schmidt RE

    . Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep 2004; 1: 122– 27

    CrossRefPubMed
67. 67.↵
    1. Robertson J,
    2. Meier M,
    3. Wall J,
    4. et al

    . Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006; 42: 1639– 46

    Abstract/FREE Full Text
68. 68.↵
    1. Riedel DJ,
    2. Pardo CA,
    3. McArthur J,
    4. et al

    . Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Prac Neurol 2006; 2: 557– 65

    CrossRef
69. 69.↵
    1. Huyst V,
    2. Lynen L,
    3. Bottieau E,
    4. et al

    . Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy. Acta Clin Belg 2007; 62: 126– 29

    PubMed
70. 70.↵
    1. Shelburne SA 3rd.,
    2. Hamill RJ

    . The immune reconstitution inflammatory syndrome. AIDS Rev 2003; 5: 67– 79

    PubMed
71. 71.↵
    1. Venkataramana A,
    2. Pardo CA

    . Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006; 67: 383– 88

    Abstract/FREE Full Text
72. 72.↵
    1. D'Amico R,
    2. Sarkar S,
    3. Yusuff J,
    4. et al

    . Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy. Scand J Infect Dis 2007; 39: 347– 50

    CrossRefPubMedWeb of Science
73. 73.↵
    1. Manabe Y,
    2. Campbell JD,
    3. Sydnor E,
    4. et al

    . Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46: 456– 62

    CrossRefPubMedWeb of Science
74. 74.↵
    1. Broom J,
    2. Woods M 2nd.,
    3. Allworth A

    . Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections. Scand J Infect Dis 2006; 38: 219– 21

    CrossRefPubMedWeb of Science
75. 75.↵
    1. Cinque P,
    2. Pierotti C,
    3. Vigano MG,
    4. et al

    . The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J Neurovirol 2001; 7: 358– 63

    CrossRefPubMedWeb of Science
76. 76.↵
    1. French MA

    . HIV/AIDS: immune reconstitution inflammatory syndrome—a reappraisal. Clin Infect Dis 2009; 48: 101– 07

    CrossRefPubMedWeb of Science
77. 77.↵
    1. Tan K,
    2. Roda R,
    3. Ostrow L,
    4. et al

    . PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009; 72: 1458– 64

    Abstract/FREE Full Text
78. 78.↵
    1. Koralnik IJ,
    2. Boden D,
    3. Mai VX,
    4. et al

    . JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52: 253– 60

    Abstract/FREE Full Text
79. 79.↵
    1. Skolasky RL,
    2. Dal Pan GJ,
    3. Olivi A,
    4. et al

    . HIV-associated primary CNS morbidity and utility of brain biopsy. J Neurol Sci 1999; 163: 32– 38

    CrossRefPubMedWeb of Science
80. 80.↵
    1. Cinque P,
    2. Scarpellini P,
    3. Vago L,
    4. et al

    . Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997; 11: 1– 17

    CrossRefPubMedWeb of Science
81. 81.↵
    1. Antinori A,
    2. Cingolani A,
    3. Lorenzini P,
    4. et al

    . Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003; 9 ( suppl 1): 47– 53

    CrossRefPubMedWeb of Science
82. 82.↵
    1. Marzocchetti A,
    2. Di Giambenedetto S,
    3. Cingolani A,
    4. et al

    . Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 2005; 43: 4175– 77

    Abstract/FREE Full Text
83. 83.↵
    1. Post MJ,
    2. Sheldon JJ,
    3. Hensley CT,
    4. et al

    . Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MR imaging, and pathologic studies. Radiology 1986; 158: 141– 48

    PubMedWeb of Science
84. 84.↵
    1. Post MJ,
    2. Tate LG,
    3. Quencer RM,
    4. et al

    . CT, MR, and pathology in HIV encephalitis and meningitis. AJNR Am J Neuroradiol 1988; 9: 469– 76

    Abstract/FREE Full Text
85. 85.↵
    1. Cuilleux MH,
    2. Steiner RE,
    3. Young IR

    . MR imaging in progressive multifocal leukoencephalopathy. AJNR Am J Neuroradiol 1986; 7: 1033– 35

    Abstract/FREE Full Text
86. 86.↵
    1. Mark AS,
    2. Atlas SW

    . Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology 1989; 173: 517– 21

    PubMedWeb of Science
87. 87.↵
    1. Thurnher MM,
    2. Thurnher SA,
    3. Muhlbauer B,
    4. et al

    . Progressive multifocal leukoencephalopathy in AIDS: initial and follow-up CT and MRI. Neuroradiology 1997; 39: 611– 18

    CrossRefPubMedWeb of Science
88. 88.↵
    1. Post MJ,
    2. Yiannoutsos C,
    3. Simpson D,
    4. et al

    . Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AJNR Am J Neuroradiol 1999; 20: 1896– 906

    Abstract/FREE Full Text
89. 89.↵
    1. Gray F,
    2. Geny C,
    3. Lescs MC,
    4. et al

    . AIDS-related progressive multifocal leukoencephalopathy limited to U fibers, responsible for subacute encephalopathy with normal CT scan findings [in French]. Arch Anat Cytol Pathol 1992; 40: 132– 37

    PubMed
90. 90.↵
    1. Trotot PM,
    2. Vazeux R,
    3. Yamashita HK,
    4. et al

    . MRI pattern of progressive multifocal leukoencephalopathy (PML) in AIDS: pathological correlations. J Neuroradiol 1990; 17: 233– 54

    PubMedWeb of Science
91. 91.↵
    1. Koralnik IJ,
    2. Schellingerhout D,
    3. Frosch MP

    . Case records of the Massachusetts General Hospital: weekly clinicopathological exercises—case 14–2004. a 66-year-old man with progressive neurologic deficits. N Engl J Med 2004; 350: 1882– 93

    CrossRefPubMed
92. 92.↵
    1. Thurnher MM,
    2. Post MJ,
    3. Rieger A,
    4. et al

    . Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 2001; 22: 977– 84

    Abstract/FREE Full Text
93. 93.↵
    1. Major EO,
    2. Ault GS

    . Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995; 8: 184– 90

    PubMedWeb of Science
94. 94.↵
    1. Takeda S,
    2. Yamazaki K,
    3. Miyakawa T,
    4. et al

    . Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology 2009; 29: 485– 93

    CrossRefPubMedWeb of Science
95. 95.↵
    1. Bernal-Cano F,
    2. Joseph JT,
    3. Koralnik IJ

    . Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. J Neurovirol 2007; 13: 474– 76

    CrossRefPubMedWeb of Science
96. 96.↵
    1. Sweeney BJ,
    2. Manji H,
    3. Miller RF,
    4. et al

    . Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 1994; 57: 994– 97

    Abstract/FREE Full Text
97. 97.↵
    1. Bienfait HP,
    2. Louwerse ES,
    3. Portegies P,
    4. et al

    . Progressive multifocal leukoencephalopathy presenting as a solitary gray matter lesion. J Neurol 1998; 245: 557– 58

    CrossRefPubMedWeb of Science
98. 98.↵
    1. Sarrazin JL,
    2. Soulie D,
    3. Derosier C,
    4. et al

    . MRI patterns of progressive multifocal leukoencephalopathy. J Neuroradiol 1995; 22: 172– 79

    PubMed
99. 99.↵
    1. Yousry TA,
    2. Major EO,
    3. Ryschkewitsch C,
    4. et al

    . Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006; 354: 924– 33

    CrossRefPubMedWeb of Science
100. 100.↵
     1. Wheeler AL,
     2. Truwit CL,
     3. Kleinschimdt-DeMasters BK,
     4. et al

     . Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 1993; 161: 1049– 51

     PubMedWeb of Science
101. 101.↵
     1. Bergui M,
     2. Bradac GB,
     3. Oguz KK,
     4. et al

     . Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. Neuroradiology 2004; 46: 22– 25

     CrossRefPubMedWeb of Science
102. 102.↵
     1. Henderson RD,
     2. Smith MG,
     3. Mowat P,
     4. et al

     . Progressive multifocal leukoencephalopathy. Neurology 2002; 58: 1825
103. 103.↵
     1. Norris DG,
     2. Niendorf T,
     3. Hoehn-Berlage M,
     4. et al

     . Incidence of apparent restricted diffusion in three different models of cerebral infarction. Magn Reson Imaging 1994; 12: 1175– 82

     CrossRefPubMed
104. 104.↵
     1. Verheul HB,
     2. Balazs R,
     3. Berkelbach van der Sprenkel JW,
     4. et al

     . Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury. NMR Biomed 1994; 7: 96– 100

     PubMedWeb of Science
105. 105.↵
     1. Qiao M,
     2. Malisza KL,
     3. Del Bigio MR,
     4. et al

     . Transient hypoxia-ischemia in rats: changes in diffusion-sensitive MR imaging findings, extracellular space, and Na+-K+-adenosinetriphosphatase and cytochrome oxidase activity. Radiology 2002; 223: 65– 75

     CrossRefPubMedWeb of Science
106. 106.↵
     1. Moseley ME,
     2. Kucharczyk J,
     3. Asgari HS,
     4. et al

     . Anisotropy in diffusion-weighted MRI. Magn Reson Med 1991; 19: 321– 26

     CrossRefPubMedWeb of Science
107. 107.↵
     1. Huisman TA,
     2. Boltshauser E,
     3. Martin E,
     4. et al

     . Diffusion tensor imaging in progressive multifocal leukoencephalopathy: early predictor for demyelination? AJNR Am J Neuroradiol 2005; 26: 2153– 56

     Abstract/FREE Full Text
108. 108.↵
     1. Usiskin SI,
     2. Bainbridge A,
     3. Miller RF,
     4. et al

     . Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy. AJNR Am J Neuroradiol 2007; 28: 285– 86

     Abstract/FREE Full Text
109. 109.↵
     1. Dousset V,
     2. Armand JP,
     3. Lacoste D,
     4. et al

     . Magnetization transfer study of HIV encephalitis and progressive multifocal leukoencephalopathy: Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AJNR Am J Neuroradiol 1997; 18: 895– 901

     Abstract/FREE Full Text
110. 110.↵
     1. Dousset V,
     2. Armand J-P,
     3. Huot P,
     4. et al

     . Magnetization transfer imaging in AIDS-related brain diseases. Neuroimaging Clin N Am 1997; 7: 447– 60

     PubMed
111. 111.↵
     1. Kreis R,
     2. Ernst T,
     3. Ross BD

     . Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424– 37

     CrossRefPubMedWeb of Science
112. 112.↵
     1. Castillo M,
     2. Kwock L,
     3. Mukherji SK

     . Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996; 17: 1– 15

     PubMedWeb of Science
113. 113.↵
     1. Hurley RA,
     2. Ernst T,
     3. Khalili K,
     4. et al

     . Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy. J Neuropsychiatry Clin Neurosci 2003; 15: 1– 6

     PubMed
114. 114.↵
     1. Brand A,
     2. Richter-Landsberg C,
     3. Leibfritz D

     . Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289– 98

     CrossRefPubMedWeb of Science
115. 115.↵
     1. Katz-Brull R,
     2. Lenkinski RE,
     3. Du Pasquier RA,
     4. et al

     . Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004; 63: 897– 900

     Abstract/FREE Full Text
116. 116.↵
     1. Menon DK,
     2. Ainsworth JG,
     3. Cox IJ,
     4. et al

     . Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992; 16: 538– 42

     PubMedWeb of Science
117. 117.↵
     1. Chong WK,
     2. Sweeney B,
     3. Wilkinson ID,
     4. et al

     . Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993; 188: 119– 24

     PubMedWeb of Science
118. 118.↵
     1. Tracey I,
     2. Carr CA,
     3. Guimaraes AR,
     4. et al

     . Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46: 783– 88

     FREE Full Text
119. 119.↵
     1. Jarvik JG,
     2. Lenkinski RE,
     3. Grossman RI,
     4. et al

     . Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993; 186: 739– 44

     PubMedWeb of Science
120. 120.↵
     1. Chang L,
     2. Ernst T,
     3. Tornatore C,
     4. et al

     . Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997; 48: 836– 45

     Abstract/FREE Full Text
121. 121.↵
     1. Nelson PK,
     2. Masters LT,
     3. Zagzag D,
     4. et al

     . Angiographic abnormalities in progressive multifocal leukoencephalopathy: an explanation based on neuropathologic findings. AJNR Am J Neuroradiol 1999; 20: 487– 94

     Abstract/FREE Full Text
122. 122.↵
     1. Iranzo A,
     2. Martí-Fábregas J,
     3. Domingo P,
     4. et al

     . Absence of thallium-201 brain uptake in progressive multifocal leukoencephalopathy in AIDS patients. Acta Neurol Scand 1999; 100: 102– 05

     CrossRefPubMedWeb of Science
123. 123.↵
     1. Lee VW,
     2. Antonacci V,
     3. Tilak S,
     4. et al

     . Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 1999; 211: 507– 12

     PubMedWeb of Science
124. 124.↵
     1. Port JD,
     2. Miseljic S,
     3. Lee RR,
     4. et al

     . Progressive multifocal leukoencephalopathy demonstrating contrast enhancement on MRI and uptake of thallium-201: a case report. Neuroradiology 1999; 41: 895– 98

     CrossRefPubMedWeb of Science
125. 125.↵
     1. Koralnik IJ

     . Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 2006; 60: 162– 73

     CrossRefPubMedWeb of Science